NCT01649401View on ClinicalTrials.gov

Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age

NACompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

November 4, 2016

Study Completion Date

November 4, 2016

Conditions

Asthma

Interventions

DEVICE

Standard nebulizer

"Nebulizer sessions for the patients will be administerd using our standard nebulizer: Micro Mist, ref 41894, Hudson RCI, distributed by Téléflex Médical."

DEVICE

PARI LC Sprint Sp nebulizer

"Nebulizer sessions for the patients will be administerd using the PARI LC Sprint Sp nebulizer.~Manufacturer: PARI GmbH Germany"

Trial Locations (1)

30029

CHU de Nîmes - Hôpital Universitaire Carémeau, Nîmes

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT01649401 - Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age | Biotech Hunter | Biotech Hunter